Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? ​

Tune in to a panel discussion around key results from a recent nationwide survey on the role of oncology advanced practitioners in cancer clinical research including current barriers to optimal care coordination and opportunities to maximize the involvement and impact of APs on the cancer research team.

Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.

Clinical trials are critical to advancing cancer treatment, but keeping your research program afloat during a pandemic is a challenge. Learn strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients.

COVID-19 impacts all facets of healthcare, including the administration of—and patient access to—clinical trials. COVID-19 poses a particularly significant challenge for oncology clinical trials, as investigational approaches are often considered standard of care for many disease types.